Table 1.
Baseline characteristics of participants enrolled.
| All participants | Well controlled | Suboptimally controlled | p value‡ | |
|---|---|---|---|---|
| N | 15 | 8 | 7 | - |
| Sex, female (%)† | 10 (66.7) | 5 (62.5) | 5 (71.4) | 1.000 |
| Age (years) | 32.2 (19.2–69.4) | 36.4 (22.6–69.4) | 21.8 (19.2–33.8) | 0.011 |
| Duration of T1D (years) | 9.7 (1.8–23.7) | 10.2 (1.8–23.7) | 9.3 (2.6–23.3) | 0.939 |
| Baseline HbA1c (%) | 7.3 (6.4–10.1) | 6.8 (6.4–7.3) | 8.4 (7.8–10.1) | <0.001 |
| BMI (kg/m²) | 21.9 (15.0–26.3) | 22.4 (17.6–26.3) | 21.9 (15.0–26.0) | 0.606 |
| Duration of pump use (years) | 6.7 (0.1–14.4) | 5.4 (1.0–11.4) | 6.9 (0.1–14.4) | 0.903 |
| Total daily insulin dosage (U/kg/day) | 0.57 (0.35–1.19) | 0.57 (0.47–1.19) | 0.64 (0.35–0.72) | 0.355 |
†
Variable is presented as number (percentage), other variables are presented as median (min–max) ‡Well controlled versus suboptimally controlled.
BMI, body mass index; HbA1c, hemoglobin A1c; T1D, type 1 diabetes.